Iranian Red Crescent Medical Journal

Published by: Kowsar

Evaluation of the Effect of Probiotics Isolated from Traditional Dairy Products on the Expression of Stx1 and Stx2 Genes of Verotoxigenic Escherichia coli (VTEC) in Laboratory Conditions

Changiz Ahmadizadeh 1 , * and Hamid Mirzaei 2
Authors Information
1 Department of Biology Ahar Branch, Islamic Azad University, Ahar, Iran
2 Department of food hygiene, Tabriz Branch, Islamic Azad University, Tabriz, Iran
Article information
  • Iranian Red Crescent Medical Journal: March 2018, 20 (3); e63544
  • Published Online: March 31, 2018
  • Article Type: Research Article
  • Received: November 1, 2017
  • Revised: December 26, 2017
  • Accepted: January 23, 2018
  • DOI: 10.5812/ircmj.63544

To Cite: Ahmadizadeh C, Mirzaei H. Evaluation of the Effect of Probiotics Isolated from Traditional Dairy Products on the Expression of Stx1 and Stx2 Genes of Verotoxigenic Escherichia coli (VTEC) in Laboratory Conditions, Iran Red Crescent Med J. 2018 ; 20(3):e63544. doi: 10.5812/ircmj.63544.

Abstract
Copyright © 2018, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24(2):160-8. doi: 10.1016/j.copbio.2012.08.005. [PubMed: 22940212].
  • 2. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog. 2010;6(9). e1001097. doi: 10.1371/journal.ppat.1001097. [PubMed: 20844578]. [PubMed Central: PMC2936549].
  • 3. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735-42. doi: 10.1038/nrmicro2876. [PubMed: 23000955].
  • 4. Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66(1):70-8. doi: 10.1136/gutjnl-2015-309800. [PubMed: 26408641].
  • 5. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. doi: 10.1038/nrgastro.2014.66. [PubMed: 24912386].
  • 6. Vanderhoof JA, Mitmesser SH. Probiotics in the management of children with allergy and other disorders of intestinal inflammation. Benef Microbes. 2010;1(4):351-6. doi: 10.3920/BM2010.0034. [PubMed: 21831774].
  • 7. Nixon AF, Cunningham SJ, Cohen HW, Crain EF. The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department. Pediatr Emerg Care. 2012;28(10):1048-51. doi: 10.1097/PEC.0b013e31826cad9f. [PubMed: 23023475]. [PubMed Central: PMC3760261].
  • 8. Suzuki N, Mittler R. Reactive oxygen species-dependent wound responses in animals and plants. Free Radic Biol Med. 2012;53(12):2269-76. doi: 10.1016/j.freeradbiomed.2012.10.538. [PubMed: 23085520].
  • 9. Franken L, Schiwon M, Kurts C. Macrophages: sentinels and regulators of the immune system. Cell Microbiol. 2016;18(4):475-87. doi: 10.1111/cmi.12580. [PubMed: 26880038].
  • 10. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8(3):171-84. doi: 10.1038/nrmicro2297. [PubMed: 20157338].
  • 11. Tarr PI, Grodon CA, Chandler WL. Shiga toxin producing Escherichia coli and hemolytic uremic syndrom. Lancet. 2005;41(219-26).
  • 12. Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol. 2004;41(3):219-26. doi: 10.1016/j.femsim.2004.03.010. [PubMed: 15196571].
  • 13. Pamela HR, Davis KC, Garstka WR, Bhunia AK. Lactat dehydrogenase realase assay from vero cells to distinguish verotoxin producing Escherichia coli from non-Vero toxin produc- ing strains. J Microbiol Methods. 2000;43:171-8.
  • 14. Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care. 2011;14(6):581-7. doi: 10.1097/MCO.0b013e32834b8082. [PubMed: 21892075].
  • 15. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123-40. doi: 10.1038/nrmicro818. [PubMed: 15040260].
  • 16. Momose Y, Hirayama K, Itoh K. Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota. Antonie Van Leeuwenhoek. 2008;93(1-2):141-9. doi: 10.1007/s10482-007-9188-9. [PubMed: 17674138].
  • 17. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med. 2011;365(8):709-17. doi: 10.1056/NEJMoa1106920. [PubMed: 21793740]. [PubMed Central: PMC3168948].
  • 18. Hughes AK, Stricklett PK, Schmid D, Kohan DE. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int. 2000;57(6):2350-9. doi: 10.1046/j.1523-1755.2000.00095.x. [PubMed: 10844605].
  • 19. Hughes AK, Stricklett PK, Kohan DE. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int. 1998;54(2):426-37. doi: 10.1046/j.1523-1755.1998.00015.x. [PubMed: 9690209].
  • 20. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem. 1993;268(21):15484-8. [PubMed: 8340376].
  • 21. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother. 1987;31(8):1231-3. doi: 10.1128/AAC.31.8.1231. [PubMed: 3307619]. [PubMed Central: PMC174909].
  • 22. Qin H, Zhang Z, Hang X, Jiang Y. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 2009;9:63. doi: 10.1186/1471-2180-9-63. [PubMed: 19331693]. [PubMed Central: PMC2674056].
  • 23. Ogunbanwo ST, Sanni AI, Onilude AA. Characterization of bacteriocin produced by Lactobacillus plantarum F1 and Lactobacillus brevis OG1. African Journal of Biotechnology. 2003;2(8):219-27. doi: 10.5897/ajb2003.000-1045.
  • 24. Wolf L, Erickson KL, Hubbard N. Bacteriocins of lactic acid bacteria. Journal Nutr. 2000;130(2):403-9.
  • 25. Lee YK, Puong KY, Ouwehand AC, Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol. 2003;52(Pt 10):925-30. doi: 10.1099/jmm.0.05009-0. [PubMed: 12972590].
  • 26. Fooks LJ, Gibson GR. Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. Anaerobe. 2003;9(5):231-42. doi: 10.1016/S1075-9964(03)00043-X. [PubMed: 16887709].
  • 27. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84(3):197-215. doi: 10.1016/S0168-1656(00)00375-8. [PubMed: 11164262].
  • 28. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol. 1997;63(2):513-8. [PubMed: 9023930]. [PubMed Central: PMC168342].
  • 29. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol. 1998;64(11):4573-80. [PubMed: 9797324]. [PubMed Central: PMC106686].
  • 30. Schauder S, Shokat K, Surette MG, Bassler BL. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol. 2001;41(2):463-76. doi: 10.1046/j.1365-2958.2001.02532.x. [PubMed: 11489131].
  • 31. Sperandio V, Torres AG, Giron JA, Kaper JB. Quorum sensing is a global regulatory mechanism in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol. 2001;183(17):5187-97. doi: 10.1128/JB.183.17.5187-5197.2001. [PubMed: 11489873]. [PubMed Central: PMC95396].
  • 32. Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature. 2002;415(6871):545-9. doi: 10.1038/415545a. [PubMed: 11823863].
  • 33. Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A. 1999;96(4):1639-44. doi: 10.1073/pnas.96.4.1639. [PubMed: 9990077]. [PubMed Central: PMC15544].
  • 34. Medellin-Pena MJ, Griffiths MW. Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol. 2009;75(4):1165-72. doi: 10.1128/AEM.01651-08. [PubMed: 19088323]. [PubMed Central: PMC2643578].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments